(SWOG S1202) A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer
Description: 
Study Number: 

NCG 252414

Phase: 
III
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01598298

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.